Sponsor Pipeline

National Cancer Center, Korea Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
35
Active Trials
14
Recruiting
6
Phase 3
9
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-09 NCT02991924
Risk Factors of Medistinal Metastasis in Endoscopic Staging of Lung Cancer
overall status: Active, Not Recruiting → Unknown
Active Trials by Phase
Phase 3
6
Phase 2
10
Not specified
19
Active Trials — top 25 of 35
NCT IDTitleConditionStatus
Phase 3
NCT04214990 Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients Aspirin Recruiting
NCT05827523 Interval Cytoreductive Surgery With or Without HIPEC for Ovarian Cancer (FOCUS /… Ovarian Cancer Recruiting
NCT01678027 Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication Gastric Cancer Active, Not Recruiting
NCT02407119 Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After… Helicobacter Pylori Infection Active, Not Recruiting
NCT02112214 Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population Gastric Cancer Active, Not Recruiting
NCT05316181 CRS & HIPEC for Platinum-Resistant Recurrent Ovarian Cancer (KOV-02R, RECOVER) Epithelial Ovarian Cancer Active, Not Recruiting
Phase 2
NCT06156527 A Randomized Phase II Study of LAZE rtiNib Alone Versus Lazertinib Plus bevaCizumab for… Lazertinib Recruiting
NCT06780748 Photo-medicine-Guided Dual Approach for Reoperation of Sentinel Lymph Nodes in Locally… Breast Cancer Recruiting
NCT06135896 Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With… Unresectable Pancreatic Cancer Recruiting
NCT07171528 Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer Ovarian Cancer Recruiting
NCT06828380 A Study Comparing Immunotherapy Alone Versus Immunotherapy Combined With Radiotherapy in… Advanced Hepatocellular Carcinoma (HCC) Recruiting
NCT06388720 The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine… Bladder Cancer Recruiting
NCT07121478 Patients With High-grade Pancreatic Neuroendocrine Tumors Neuroendocrine Tumor of Pancreas Enrolling by Invitation
NCT07297654 First-Line Lenvatinib in Child-Pugh B Patients With HCC Unsuitable for Curative Treatment Advanced Hepatocellular Carcinoma Not Yet Recruiting
NCT05036434 Phase II Trial of Pembrolizumab Plus Lenvatinib in Advanced Adrenal Cortical Carcinoma Adrenocortical Carcinoma Active, Not Recruiting
NCT03756298 Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple… Triple Negative Breast Cancer Active, Not Recruiting
Not specified
NCT05982691 Development of Asian Consortium for Data Collection and Clinical Trial of CNS Tumors CNS Germinoma Recruiting
NCT04890171 Comparison of Endoscopic Resection and Surgery for Early Gastric Cancer With… Stomach Cancer Recruiting
NCT06780735 Surgical Outcome of BCS Using ICG-F in Breast Cancer Patients After Preoperative… Breast Neoplasms Recruiting
NCT06969742 Development and Application of Intervention Program to Improve Mental Health and Quality… Pediatric Solid Tumors Recruiting
NCT06168292 Intraductal Radiofrequency Thermoablation and Radiotherapy Combined Treatment for… Biliary Tract Carcinoma Recruiting
NCT07699705 Prospective Study of Ultrahypofractionated Proton Beam Therapy for Localized Prostate… Prostate Neoplasm Recruiting
NCT04466124 Prospective Cohort Study of Liver Cancer Patients Treated With Proton Beam Therapy Liver Cancer Enrolling by Invitation
NCT04466189 Prospective Cohort Study of Pancreatic Cancer Patients Treated With Proton Beam Therapy Pancreas Cancer Enrolling by Invitation
NCT04203849 Prospective Cohort Study of Breast Cancer Patients Treated With Radiotherapy Breast Cancer Enrolling by Invitation
See all 35 active National Cancer Center, Korea trials with filters →
Disease Areas
Get alerts when National Cancer Center, Korea's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free